The Safety and Tolerability Profile of Vilazodone, A Novel Antidepressant for the Treatment of Major Depressive Disorder

OBJECTIVE: Vilazodone is a selective serotonin reuptake inhibitor and 5-HT(1A) receptor partial agonist approved for the treatment of major depressive disorder (MDD). This report summarizes the safety and tolerability of vilazodone 40 mg/day during short- and long-term treatment of adult MDD. METHOD...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Psychopharmacol Bull
Päätekijät: Liebowitz, Michael, Croft, Harry A., Kajdasz, Daniel K., Whalen, Heidi, Gallipoli, Susan, Athanasiou, Maria, Reed, Carol R.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: MedWorks Media Global 2011
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5044546/
https://ncbi.nlm.nih.gov/pubmed/27738360
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia